Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of alpha1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3].
Molecular Weight:
387.43
CAS Number:
[63590-64-7]
Formula:
C19H25N5O4
Target:
Others|||Adrenergic Receptor
T61729
* VAT and and shipping costs not included. Errors and price changes excepted
